These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8117411)

  • 21. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases.
    Lamb H; Christie J; Singleton AB; Leake A; Perry RH; Ince PG; McKeith IG; Melton LM; Edwardson JA; Morris CM
    Neurology; 1998 Feb; 50(2):388-91. PubMed ID: 9484359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of plasma alpha 1-antichymotrypsin levels in Alzheimer disease patients and controls and their genetic controls.
    Wang X; DeKosky ST; Ikonomovic MD; Kamboh MI
    Neurobiol Aging; 2002; 23(3):377-82. PubMed ID: 11959399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain-specific fatty acid-binding protein is elevated in serum of patients with dementia-related diseases.
    Teunissen CE; Veerhuis R; De Vente J; Verhey FR; Vreeling F; van Boxtel MP; Glatz JF; Pelsers MA
    Eur J Neurol; 2011 Jun; 18(6):865-71. PubMed ID: 21143341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation of microRNA-103 and microRNA-107 as potential blood-based biomarkers for disease risk and progression of Alzheimer's disease.
    Wang J; Chen C; Zhang Y
    J Clin Lab Anal; 2020 Jan; 34(1):e23006. PubMed ID: 31420923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic association analysis of alpha-1-antichymotrypsin polymorphism in Parkinson's disease.
    Wang YC; Liu HC; Liu TY; Hong CJ; Tsai SJ
    Eur Neurol; 2001; 45(4):254-6. PubMed ID: 11385264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk.
    Licastro F; Pedrini S; Ferri C; Casadei V; Govoni M; Pession A; Sciacca FL; Veglia F; Annoni G; Bonafè M; Olivieri F; Franceschi C; Grimaldi LM
    Ann Neurol; 2000 Sep; 48(3):388-91. PubMed ID: 10976648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease.
    Mateo I; Infante J; Sánchez-Juan P; García-Gorostiaga I; Rodríguez-Rodríguez E; Vázquez-Higuera JL; Berciano J; Combarros O
    Acta Neurol Scand; 2010 Feb; 121(2):136-8. PubMed ID: 19785642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio.
    Wada H
    Intern Med; 1998 Jun; 37(6):509-13. PubMed ID: 9678683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
    Wennström M; Surova Y; Hall S; Nilsson C; Minthon L; Hansson O; Nielsen HM
    PLoS One; 2015; 10(8):e0135458. PubMed ID: 26270969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low LDL cholesterol,
    Benn M; Nordestgaard BG; Frikke-Schmidt R; Tybjærg-Hansen A
    BMJ; 2017 Apr; 357():j1648. PubMed ID: 28438747
    [No Abstract]   [Full Text] [Related]  

  • 32. Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy.
    Kuiper MA; Mulder C; van Kamp GJ; Scheltens P; Wolters EC
    J Neural Transm Park Dis Dement Sect; 1994; 7(2):109-14. PubMed ID: 7710663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical comparison of dementia in Parkinson's and Alzheimer's disease.
    Marschall I; Dal-Bianco P; Maly J; Auff E; Hufgard J; Mraz M; Deecke L
    J Neural Transm Suppl; 1991; 33():81-92. PubMed ID: 1661322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma alpha1-antichymotrypsin in Alzheimer's disease; relationships with APOE genotypes.
    Scacchi R; Ruggeri M; Gambina G; Martini MC; Ferrari G; Corbo RM
    Neurobiol Aging; 2001; 22(3):413-6. PubMed ID: 11378247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corpus callosum in neurodegenerative diseases: findings in Parkinson's disease.
    Wiltshire K; Foster S; Kaye JA; Small BJ; Camicioli R
    Dement Geriatr Cogn Disord; 2005; 20(6):345-51. PubMed ID: 16192724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?
    Licastro F; Pedrini S; Caputo L; Annoni G; Davis LJ; Ferri C; Casadei V; Grimaldi LM
    J Neuroimmunol; 2000 Feb; 103(1):97-102. PubMed ID: 10674995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic association between susceptibility to Parkinson's disease and alpha1-antichymotrypsin polymorphism.
    Yamamoto M; Kondo I; Ogawa N; Asanuma M; Yamashita Y; Mizuno Y
    Brain Res; 1997 Jun; 759(1):153-5. PubMed ID: 9219874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease.
    Irizarry MC; Yao Y; Hyman BT; Growdon JH; Praticò D
    Neurodegener Dis; 2007; 4(6):403-5. PubMed ID: 17934322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.
    Almeida OP; Burton EJ; McKeith I; Gholkar A; Burn D; O'Brien JT
    Dement Geriatr Cogn Disord; 2003; 16(2):57-63. PubMed ID: 12784028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.